Skip to main content

Published locations for Immunotherapy drug teplizumab may stall onset of type 1 diabetes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Immunotherapy drug teplizumab may stall onset of type 1 diabetes

User login

  • Reset your password
  • /content/immunotherapy-drug-teplizumab-may-stall-onset-type-1-diabetes
  • /fedprac/article/202556/diabetes/immunotherapy-drug-teplizumab-may-stall-onset-type-1-diabetes
  • /pediatricnews/article/202556/diabetes/immunotherapy-drug-teplizumab-may-stall-onset-type-1-diabetes
  • /clinicalendocrinologynews/article/202556/diabetes/immunotherapy-drug-teplizumab-may-stall-onset-type
  • /pediatrics/article/202556/diabetes/immunotherapy-drug-teplizumab-may-stall-onset-type-1-diabetes
  • /endocrinology/article/202556/diabetes/immunotherapy-drug-teplizumab-may-stall-onset-type-1-diabetes
  • /type-2-diabetes-icymi/article/202556/diabetes/immunotherapy-drug-teplizumab-may-stall-onset-type-1